1. Home
  2. VYGR vs LPRO Comparison

VYGR vs LPRO Comparison

Compare VYGR & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.79

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo Open Lending Corporation

LPRO

Open Lending Corporation

HOLD

Current Price

$1.41

Market Cap

167.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
LPRO
Founded
2013
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
167.8M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
VYGR
LPRO
Price
$3.79
$1.41
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$17.00
$2.83
AVG Volume (30 Days)
527.4K
513.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
N/A
$306.66
Revenue Next Year
$71.77
$7.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$0.70
52 Week High
$5.55
$5.24

Technical Indicators

Market Signals
Indicator
VYGR
LPRO
Relative Strength Index (RSI) 47.48 32.36
Support Level $2.79 $0.70
Resistance Level $3.73 $1.96
Average True Range (ATR) 0.21 0.12
MACD 0.00 -0.02
Stochastic Oscillator 54.65 15.58

Price Performance

Historical Comparison
VYGR
LPRO

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About LPRO Open Lending Corporation

Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.

Share on Social Networks: